Home >
Access the latest news, business developments, company updates, industry trends, events and more.
BioCT invites nominations for this year’s Entrepreneur of the Year Award. Established by BioCT and Shipman & Goodwin, the Entrepreneur of the Year Award acknowledges the importance of showcasing the unique accomplishments...
Cybrexa and Exelixis have entered into an exclusive collaboration agreement providing Exelixis the right to acquire CBX-12 (alphalex™ exatecan), a clinical-stage, first-in-class peptide-drug conjugate (PDC) that...
View this email in your browser Weekly Roundup – November 3, 2022 Congratulations to Infinant Health on the official opening of the Infinant Health Executive Global Headquarters in...
Greg Sotzing, a chemist and professor at UConn, is manipulating the compounds found in cannabis into unexpected forms. For example, Sotzing has turned CBD, found in hemp,...
BioCT invites nominations for this year’s Entrepreneur of the Year Award. Established by BioCT and Shipman & Goodwin, the Entrepreneur of the Year Award acknowledges the importance of showcasing the unique accomplishments...
Normunity, which combines the words normal and immunity, is a West Haven and Boston-based biotech that addresses T cell exclusion — that is, when T...
Shoreline Biome, the developer of the Titan-1TM microbiome research, discovery, and testing platform, has changed its name to Intus Biosciences. Intus—a Latin word for “inside”— reflects...
Women In Bio Connecticut (WIB-CT) recently celebrated the inaugural launch of the 3.8 Initiative, named for the March 8 International Women’s Day, a 10-month program dedicated...
View this email in your browser Weekly Roundup – October 27, 2022 “Whether you are an innovator developing new IMPs without previous stability data or a...
Normunity has announced a $65 million Series A financing. Normunity’s new class of agents, called immune normalizers, target previously undiscovered mechanisms of immune disruption in cancer....